LÖSLICHES CD5 ODER CD6 PROTEIN ZUR BEHANDLUNG VON KREBS ODER TUMOREN ODER ZU VERVENDUNG ALS ADJUVANS

European patent · EP2714066 · Deleted

Register entry

Publication number
EP2714066
Application number
EP12726052
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 29, 2012
Published
Apr 9, 2014
Granted
Apr 5, 2017
Deleted
May 31, 2017
Reason
Annual fee unpaid
IPC classes
A61K 38/17 (2006.01)
C07K 14/705 (2006.01)
A01K 67/027 (2006.01)
A61K 31/475 (2006.01)
A61K 31/704 (2006.01)
A61K 39/39 (2006.01)
A61P 35/00 (2006.01)
Priority
EP 11382172 26.05.2011
PCT application
PCT/EP2012/059966 29.05.2012
PCT publication
WO2012/160215 29.11.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 20, 2017

    Deleted, fee unpaid

    Published in Swissreg on 20.12.2017

  2. Apr 5, 2017

    Granted

    Published in Swissreg on 05.04.2017

Parties

Holder

Fundació Clínic per a la Recerca Biomèdica

C/Rosselló, 149-153, 08036 Barcelona, ES

Hospital Clinic i Provincial de Barcelona

C/Villaroel 170, 08036 Barcelona, ES

Universitat de Barcelona

Centro de Patentes de la UB C. Baldiri Reixac, 4, 08028 Barcelona, ES

Inventor

LOZANO SOTO, Francisco

E-08036 Barcelona, ES

MARTÍNEZ, Vanessa Gabriela

E-08036 Barcelona, ES

FENUTRIA AUMESQUET, Rafael

E-08036 Barcelona, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.